Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of FGFR1 mRNA | decreases expression | 19933214
|
C117011 |
3-(4-dimethylamino-benzylidenyl)-2-indolinone |
3-(4-dimethylamino-benzylidenyl)-2-indolinone results in decreased activity of FGFR1 protein | decreases activity | 15728459
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of FGFR1 mRNA | decreases expression | 12419474
|
D000117 |
Acetylglucosamine |
Acetylglucosamine analog promotes the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|increases reaction | 12440867
|
D020106 |
Acrylamide |
Acrylamide analog promotes the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|increases reaction | 12440867
|
D020106 |
Acrylamide |
Acrylamide analog promotes the reaction [FGFR1 protein binds to FGFR1 protein] | affects binding|increases reaction | 14733594
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in decreased expression of FGFR1 mRNA | decreases expression | 17023530
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FGFR1 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of FGFR1 mRNA | decreases expression | 12558987
|
C463061 |
AP20187 |
AP20187 results in increased activity of FGFR1 protein mutant form | increases activity | 12654294
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of FGFR1 mRNA | decreases expression | 15761015 19128835
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased phosphorylation of FGFR1 protein mutant form | decreases phosphorylation | 17027752
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of FGFR1 mRNA | increases expression | 20458559 17258074
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of FGFR1 mRNA | increases expression | 20678512
|
D001786 |
Blood Glucose |
FGFR1 protein affects the abundance of Blood Glucose | affects abundance | 11130726
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in decreased expression of FGFR1 mRNA | decreases expression | 12760830
|
D002118 |
Calcium |
[Calcium co-treated with Calcitriol] affects the expression of FGFR1 mRNA | affects cotreatment|affects expression | 15913539
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of FGFR1 mRNA | decreases expression | 17484886
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] | decreases reaction|increases expression | 12805413
|
D003609 |
Dactinomycin |
Dactinomycin inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] | decreases reaction|increases expression | 12805413
|
C014347 |
decitabine |
decitabine results in decreased expression of FGFR1 mRNA | decreases expression | 17785578
|
D003976 |
Diazinon |
Diazinon results in decreased expression of FGFR1 mRNA | decreases expression | 17589599
|
D003976 |
Diazinon |
Diazinon results in increased expression of FGFR1 mRNA | increases expression | 19130878
|
D004026 |
Dieldrin |
Dieldrin affects the expression of FGFR1 mRNA | affects expression | 19130878
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of FGFR1 mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
FGFR1 protein results in increased susceptibility to Diethylnitrosamine | increases response to substance | 19009564
|
D002117 |
Calcitriol |
[Calcium co-treated with Calcitriol] affects the expression of FGFR1 mRNA | affects cotreatment|affects expression | 15913539
|
C472511 |
dimethylarsinous acid |
dimethylarsinous acid results in decreased expression of FGFR1 mRNA | decreases expression | 16507463
|
D004610 |
Ellagic Acid |
Ellagic Acid results in decreased expression of FGFR1 mRNA | decreases expression | 12002526
|
C024552 |
estrone benzoate |
estrone benzoate inhibits the reaction [Progesterone results in decreased expression of FGFR1 mRNA alternative form] | decreases expression|decreases reaction | 15120423
|
D005576 |
Forskolin |
Forskolin results in increased expression of FGFR1 mRNA | increases expression | 10320526
|
D019812 |
Heparan Sulfate Proteoglycans |
[Heparan Sulfate Proteoglycans binds to FGF2 protein binds to FGFR1 protein] which binds to KAL1 protein | affects binding | 15548653
|
D019812 |
Heparan Sulfate Proteoglycans |
Heparan Sulfate Proteoglycans promotes the reaction [FGF1 protein binds to and results in increased activity of FGFR1 protein] | affects binding|increases activity|increases reaction | 15767480
|
D019812 |
Heparan Sulfate Proteoglycans |
Heparan Sulfate Proteoglycans affects the reaction [FGF1 protein binds to FGFR1 protein] | affects binding|affects reaction | 10336501
|
D019812 |
Heparan Sulfate Proteoglycans |
Heparan Sulfate Proteoglycans affects the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|affects reaction | 10336501
|
D019812 |
Heparan Sulfate Proteoglycans |
Heparan Sulfate Proteoglycans affects the activity of FGFR1 protein | affects activity | 15923150
|
D006493 |
Heparin |
Heparin promotes the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|increases reaction | 12440867
|
D006493 |
Heparin |
Heparin binds to FGFR1 protein binds to FGF2 protein | affects binding | 15096041
|
D006493 |
Heparin |
Heparin promotes the reaction [FGFR1 protein binds to FGF1 protein] | affects binding|increases reaction | 1379594
|
D006493 |
Heparin |
Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein] | affects binding|increases reaction | 1379594
|
D006493 |
Heparin |
Heparin promotes the reaction [FGF2 protein results in increased activity of FGFR1 protein] | increases activity|increases reaction | 12799194
|
D006497 |
Heparitin Sulfate |
SULF1 protein inhibits the reaction [Heparitin Sulfate results in increased activity of FGFR1 protein] | decreases reaction|increases activity | 15051888
|
D006497 |
Heparitin Sulfate |
FGF1 protein binds to Heparitin Sulfate binds to FGFR1 protein | affects binding | 12604602
|
D006497 |
Heparitin Sulfate |
Heparitin Sulfate analog results in increased activity of FGFR1 protein alternative form | increases activity | 12460940
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide promotes the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|increases reaction | 8849686
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of FGFR1 mRNA | decreases expression | 12419474
|
D007608 |
Kainic Acid |
Kainic Acid results in increased expression of FGFR1 mRNA | increases expression | 7649223
|
D008727 |
Methotrexate |
FGFR1 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of FGFR1 mRNA | increases expression | 20713471
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased expression of and affects the localization of FGFR1 protein | affects localization|increases expression | 15581186
|
D009020 |
Morphine |
Morphine results in increased expression of FGFR1 mRNA | increases expression | 15183518
|
D009287 |
Naphthyridines |
Naphthyridines analog results in decreased activity of FGFR1 protein | decreases activity | 16000000
|
D009844 |
Oligosaccharides |
Oligosaccharides promotes the reaction [FGF1 protein binds to and results in increased activity of FGFR1 protein] | affects binding|increases activity|increases reaction | 11714710
|
D009844 |
Oligosaccharides |
Oligosaccharides promotes the reaction [FGF1 protein binds to FGFR1 protein alternative form] | affects binding|increases reaction | 9174673
|
C041786 |
palm oil |
palm oil results in decreased expression of FGFR1 mRNA | decreases expression | 18042831
|
C107527 |
PD 161570 |
PD 161570 inhibits the reaction [FGFR1 protein results in increased phosphorylation of FGFR1 protein] | decreases reaction|increases phosphorylation | 12805413
|
C113399 |
PD 166866 |
PD 166866 results in decreased activity of FGFR1 protein | decreases activity | 15522930
|
C113399 |
PD 166866 |
PD 166866 inhibits the reaction [FGF1 protein results in increased expression of FGFR1 protein] | decreases reaction|increases expression | 15773903
|
C113399 |
PD 166866 |
PD 166866 inhibits the reaction [FGFR1 protein results in increased phosphorylation of FGFR1 protein] | decreases reaction|increases phosphorylation | 12805413
|
C113399 |
PD 166866 |
PD 166866 results in decreased activity of FGFR1 protein | decreases activity | 15121739 15773903
|
D030421 |
Peroxynitrous Acid |
FGFR1 protein alternative form affects the susceptibility to Peroxynitrous Acid | affects response to substance | 12573278
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of FGFR1 mRNA | increases expression | 12832660
|
D011374 |
Progesterone |
estrone benzoate inhibits the reaction [Progesterone results in decreased expression of FGFR1 mRNA alternative form] | decreases expression|decreases reaction | 15120423
|
D011374 |
Progesterone |
Progesterone results in decreased expression of FGFR1 mRNA alternative form | decreases expression | 15120423
|
C059514 |
resveratrol |
resveratrol results in increased expression of FGFR1 mRNA | increases expression | 12002526
|
C010327 |
salinomycin |
salinomycin results in decreased expression of FGFR1 mRNA | decreases expression | 19682730
|
D012643 |
Selenium |
Selenium results in increased expression of FGFR1 protein | increases expression | 18583539
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of FGFR1 mRNA | decreases expression | 16876216
|
C016104 |
sodium bichromate |
sodium bichromate results in decreased expression of FGFR1 mRNA | decreases expression | 12760830
|
C105686 |
SU 5402 |
SU 5402 results in decreased activity of FGFR1 protein | decreases activity | 16188231 16091734 16154193
|
C105686 |
SU 5402 |
SU 5402 results in decreased activity of FGFR1 protein mutant form | decreases activity | 16103074
|
C105686 |
SU 5402 |
SU 5402 results in decreased activity of FGFR1 protein | decreases activity | 12421715
|
C105686 |
SU 5402 |
SU 5402 results in increased expression of FGFR1 mRNA alternative form | increases expression | 12421715
|
C105686 |
SU 5402 |
SU 5402 results in decreased activity of FGFR1 protein | decreases activity | 15631803 15936332 15298682 16326079 16103074 12704805 15255957
|
C412603 |
SU 6668 |
SU 6668 results in decreased phosphorylation of and results in decreased activity of FGFR1 protein | decreases activity|decreases phosphorylation | 16144927
|
C412603 |
SU 6668 |
SU 6668 results in decreased activity of FGFR1 protein | decreases activity | 15788688 15551349 14760097 16132614
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of FGFR1 mRNA | increases expression | 16150908
|
D014284 |
Triiodothyronine |
Cycloheximide inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] | decreases reaction|increases expression | 12805413
|
D014284 |
Triiodothyronine |
Dactinomycin inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] | decreases reaction|increases expression | 12805413
|
D014284 |
Triiodothyronine |
Triiodothyronine promotes the reaction [FGF2 protein promotes the reaction [FGFR1 protein results in increased phosphorylation of FGFR1 protein]] | increases phosphorylation|increases reaction | 12805413
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of FGFR1 mRNA | increases expression | 12805413
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of FGFR1 protein | increases expression | 12805413
|
D013629 |
Tamoxifen |
FGFR1 protein results in decreased susceptibility to Tamoxifen | decreases response to substance | 20179196
|
D013654 |
Taurine |
Taurine results in decreased expression of FGFR1 mRNA | decreases expression | 16579726
|
D013739 |
Testosterone |
Testosterone results in increased expression of FGFR1 mRNA | increases expression | 7536664
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of FGFR1 mRNA] | decreases reaction|increases expression | 15667827
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of FGFR1 mRNA | decreases expression | 19933214
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FGFR1 mRNA | increases expression | 17586704
|
D014028 |
Tobacco Smoke Pollution |
Tobacco Smoke Pollution results in decreased expression of FGFR1 mRNA | decreases expression | 15289447
|
D024505 |
Tocopherols |
Tocopherols results in decreased expression of FGFR1 mRNA | decreases expression | 15144885
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of FGFR1 mRNA | increases expression | 16604517
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of FGFR1 protein | increases expression | 15389522
|
D014508 |
Urea |
Urea analog results in decreased activity of FGFR1 protein | decreases activity | 16000000
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.92 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
6.56 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.56 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.95 | 18287403 |
MESH:D000168 |
Acrocephalosyndactylia |
marker/mechanism |
|
| |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.30 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.55 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.11 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
4.11 | 15113128 15688392 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Tobacco Smoke Pollution |
4.90 | 15814487 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
9.05 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
9.05 | 10545420 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
9.05 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
13.72 | 19052882 18056438 19061943 17162532 17620307 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
13.72 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
13.72 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.07 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.27 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
3.73 | 16487989 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.12 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.41 | 16183991 16162502 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.69 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.41 | 11748828 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.22 | 7506515 |
MESH:C537780 |
Antley-Bixler syndrome |
marker/mechanism |
|
| |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.29 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.15 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.15 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
6.46 | 17286800 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tobacco Smoke Pollution |
6.46 | 19898480 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
6.46 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.13 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
5.65 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
5.65 | 17967414 16873680 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.81 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
17.41 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
17.41 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
17.41 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
17.41 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.16 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.34 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Dactinomycin |
4.91 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.31 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.71 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.66 | 15845082 15380490 15665606 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
8.58 | 19211983 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
8.58 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
SU 6668 |
5.41 | 15739567 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20179196 |
MESH:D001943 |
Breast Neoplasms |
|
Acrylamide |
15.86 | 16253758 18183576 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
15.86 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
15.86 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
15.86 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
15.86 | 11859874 15770527 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
15.86 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
15.86 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
15.86 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
15.86 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
15.86 | 16253758 14633655 11306469 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
15.86 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
15.86 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
15.86 | 19682730 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
15.86 | 19084267 18351453 20544844 19487384 19155303 19059307 18629630 18425577 19142967 20065188 15565566 19289846 16202921 16818667 15668708 19244106 18855134 17049068 20135344 19066611 11161223 17440819 19011961 21138602 18815881 19288272 17261762 18821012 20390343 16273361 19115204 18984771 19221464 20005174 17893378 19103187 19189212 18997820 19189210 16873071 21152245 20859285 19200415 17242785 19410462 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
15.86 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
15.86 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
15.86 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.97 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.76 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.18 | 10355542 16124888 3786805 18705752 15721981 16050911 15700767 16192424 16227642 16097048 15673190 16011737 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
6.68 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.68 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.90 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.53 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
11.94 | 15553829 14691202 15073043 16217749 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
11.94 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.94 | 17428255 18506893 18971187 3084413 21159647 18393292 18785209 18788625 16779866 19701751 11831363 16569478 19335982 19539802 19822196 18210153 18665156 20935162 16807293 19052882 10737359 17978847 19394651 19919837 20084675 17761372 19418558 16935385 20512989 10672840 20007298 20727157 20432363 17138121 20524982 17055752 18056438 16288022 18691550 17173139 16681979 16878318 3581430 19171122 19519916 20514400 18978308 20214788 16830150 16540662 19208518 19383236 20101231 16502159 18494052 19107877 17162532 16698587 16328049 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
11.94 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.94 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
11.94 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.94 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.37 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
3.98 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Tobacco Smoke Pollution |
3.18 | 11212258 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.24 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.57 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
15.11 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
15.11 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
15.11 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
15.11 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tobacco Smoke Pollution |
15.11 | 11212258 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
15.11 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.08 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.00 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.11 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.11 | 15458977 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
6.43 | 12484553 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.43 | 17460283 |
MESH:D002418 |
Cattle Diseases |
|
Acrylamide |
4.82 | 12510666 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
12.47 | 21159647 17174075 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
12.47 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
12.47 | 7505956 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.47 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.97 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.42 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.58 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.58 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.36 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.53 | 16461808 |
MESH:D002971 |
Cleft Lip |
marker/mechanism |
|
| 17963255 |
MESH:D002972 |
Cleft Palate |
marker/mechanism |
|
| 17963255 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.76 | 15668235 8697196 16354765 15340226 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.76 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
12.57 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
12.57 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
12.57 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.45 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.45 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.07 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.07 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.07 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.54 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.33 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.60 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 12514106 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.65 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
4.65 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.65 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.65 | 10589399 16925845 17551590 9224671 9664655 14991402 9142499 9125849 8800419 9211117 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
3.71 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.52 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.76 | 19031437 |
MESH:D003866 |
Depressive Disorder |
marker/mechanism |
|
| 16861106 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.11 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
4.54 | 20191521 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.26 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Blood Glucose |
6.24 | 19586609 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.24 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.24 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
5.43 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
7.30 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.30 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.89 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Morphine |
3.95 | 2540324 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
9.57 | 16227642 6884620 19085960 15027814 3732212 11566570 16177239 19336974 21278145 3786805 17522070 10092053 9327722 7179309 10915739 6623471 7440962 7120509 15968718 15998439 4309450 2869522 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.57 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
9.57 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
9.57 | 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.57 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.29 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
2.99 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.18 | 16487989 |
MESH:D004487 |
Edema |
|
pirinixic acid |
8.28 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
8.28 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.28 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.85 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.85 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
17.18 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
17.18 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
17.18 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
17.18 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.49 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.01 | 20544844 17893378 19155303 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.01 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.14 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.14 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.25 | 17923197 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.49 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.13 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.26 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.26 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
23.58 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
23.58 | 15959796 61145 12795759 16045604 12631006 16239168 17595544 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
23.58 | 18296743 19004024 19551842 17967931 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
23.58 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
23.58 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
23.58 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.83 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.86 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.91 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.57 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
10.17 | 14633661 10962813 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
10.17 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
16.24 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
16.24 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.24 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
16.24 | 17994277 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.22 | 7506515 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.67 | 16904648 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.06 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
6.08 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.08 | 17312396 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
6.25 | 9825942 |
MESH:D005910 |
Glioma |
|
SU 6668 |
6.25 | 15739567 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.96 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
4.54 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
6.37 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.37 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.53 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.33 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.33 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.59 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
5.59 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.78 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
7.67 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
7.67 | 16487989 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.28 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.28 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.57 | 16876885 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.02 | 17019078 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.65 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.42 | 16959395 15340226 18606429 16354765 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
2.72 | 16870215 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.68 | 17019078 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.91 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
7.38 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
7.38 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.96 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
7.40 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
7.40 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.65 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.49 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.76 | 17488730 |
MESH:D007006 |
Hypogonadism |
marker/mechanism |
|
| |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.13 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.57 | 17426086 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.22 | 7506515 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
9.48 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
9.48 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Acrylamide |
9.04 | 11020651 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
9.04 | 10630421 |
MESH:D007248 |
Infertility, Male |
|
Acrylamide |
16.57 | 12507653 11020651 15355880 15749267 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
16.57 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
16.57 | 12948887 16466525 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
16.57 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
16.57 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
18.75 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
18.75 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
18.75 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
18.75 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
18.75 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
18.75 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tobacco Smoke Pollution |
18.75 | 18590791 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
8.99 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
8.99 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
9.85 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
9.85 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
9.85 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.17 | 17994277 |
MESH:C537559 |
Jackson-Weiss syndrome |
marker/mechanism |
|
| |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.09 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.09 | 15992940 17551590 |
MESH:D017436 |
Kallmann Syndrome |
marker/mechanism |
|
| |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
5.15 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.15 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.18 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
8.18 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.55 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.42 | 16316344 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
4.53 | 9562676 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
8.49 | 15070760 |
MESH:D007938 |
Leukemia |
|
decitabine |
8.49 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
8.49 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.24 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.69 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.96 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
12.79 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
12.79 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
12.79 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.24 | 16467208 17050201 20471514 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
5.24 | 19010910 18206229 17679729 19387464 18460780 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.24 | 19850784 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.83 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
10.30 | 11161223 12018890 17649720 16330433 16823087 16331271 16891316 12679006 19035177 15336539 19642359 15622746 19075265 17869043 9834237 19225113 16112521 17217047 12712474 16966277 15213294 15748426 11468182 17107899 17712046 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
10.30 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
10.30 | 16823087 16766008 17294898 17217047 17339181 19029980 16891316 16140955 17107899 17368321 17361223 19035177 9834237 16935935 17712046 17301526 19075265 17506722 17649720 19642359 16788101 19225113 15748426 12679006 16331271 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.76 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
6.93 | 15526292 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
6.93 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.70 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
12.71 | 16943688 21278145 16239168 16221502 11408273 11903743 17157831 17174718 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
12.71 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
12.71 | 20032147 19638242 18665156 18522880 18407596 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
12.71 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
9.23 | 15925388 12741479 14512876 15362042 17557913 17761835 15730626 17721639 18376398 18339082 18210741 10355542 12649538 18279442 15673190 15123356 17805973 12586293 20821823 15996030 14716496 15818738 17869086 18205269 18472094 17708605 17922224 18187930 12898905 18156304 17698563 15057751 16136751 12958196 15650968 18429990 16015684 18481824 12666154 15959796 18277467 14716833 18251166 18263696 18412020 17631135 16248980 17976157 14748882 16011737 12632514 18418968 18472332 18395095 14724832 12609069 18054572 13678700 12445418 16192424 17714472 12667390 15931870 18420326 16638106 12632512 12389079 17525996 12546737 12445421 18395914 17640975 15338365 17766677 15370692 15876570 14620537 17900296 11481614 16097048 17481882 18166357 18006644 16033810 15893842 18705752 17823541 18317297 17944888 15052691 16027843 17565644 16116963 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Heparin |
9.23 | 16904936 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
9.23 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
9.23 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
9.23 | 15931870 15893842 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
9.23 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
9.23 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.41 | 16246199 15830285 17285989 16964402 15720792 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.41 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.56 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.15 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
24.55 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
24.55 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
24.55 | 8742319 9539021 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
24.55 | 19256749 15885732 19638242 20101389 19254457 19996281 18977376 18648771 18754104 21167192 19426721 19255062 19499222 20583210 19690152 15175105 19294768 2422723 12771043 9163691 20452335 19090486 20137499 19073162 21278145 19833225 18644402 20434301 12112319 21047994 19812893 20501860 19850985 20405173 18978307 20118626 19551842 21071580 16942905 20492335 19642983 2862719 10737359 19427195 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
24.55 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
24.55 | 19812893 20405173 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
24.55 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
24.55 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
24.55 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
14.29 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
14.29 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.29 | 17854601 19009564 17942915 18775883 19519916 18079962 2563599 18093689 17174075 19539802 19126423 18544905 19004024 16267830 18253720 18282651 9362446 16842330 3124819 21159647 18164116 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
14.29 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.29 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.87 | 15213294 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
4.86 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.74 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.39 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
11.05 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
11.05 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
11.05 | 1399818 11893704 16271038 17909032 15390079 20512841 16337739 10545420 7750092 6695378 9230183 20970405 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
11.05 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
11.05 | 19931552 16712894 17077188 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
11.05 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
11.05 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tobacco Smoke Pollution |
11.05 | 16288123 12111688 11091918 3440675 |
MESH:D008223 |
Lymphoma |
|
decitabine |
10.12 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
10.12 | 17352296 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
10.12 | 16257854 11418001 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
8.64 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.64 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.36 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.96 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.96 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
22.07 | 14999141 11807958 17020996 19196723 12931682 10767621 16944150 15113128 14633655 15313902 15688392 16619500 17131329 16051031 16827153 11751437 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
22.07 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
22.07 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
22.07 | 19682730 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
22.07 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
22.07 | 11731420 19196723 14580682 19196722 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tocopherols |
22.07 | 17927505 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
3.92 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.50 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
8.17 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
resveratrol |
8.17 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
8.17 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
8.17 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.17 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.57 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.82 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
5.71 | 15107826 |
MESH:D008654 |
Mesothelioma |
|
Tocopherols |
5.71 | 15878867 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.82 | 17112576 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
4.89 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Tobacco Smoke Pollution |
3.87 | 15006635 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
4.66 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
9.53 | 11468182 19417148 15949261 14977855 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
9.53 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
9.53 | 16267019 17049120 17935668 16490592 17164350 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.25 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.91 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.04 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
10.10 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
10.10 | 19010910 16882708 19157545 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
10.10 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
4.74 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
4.74 | 17188708 17015251 16525036 17125593 16317513 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.35 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.35 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.46 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.14 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.37 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
4.76 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
4.76 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.28 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
15.34 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
15.34 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
15.34 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
15.34 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
15.34 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
15.34 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
11.94 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
11.94 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
11.94 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.37 | 19200415 19189210 19196722 |
MESH:D009410 |
Nerve Degeneration |
|
Acrylamide |
4.21 | 12387366 11264303 12387367 |
MESH:D009422 |
Nervous System Diseases |
|
Acrylamide |
4.46 | 12507653 12164553 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
12.99 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
12.99 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
12.99 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
9.68 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
9.68 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
9.68 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
4.87 | 11555667 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
6.83 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
6.83 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.83 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.49 | 20387270 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
3.78 | 20132043 19632207 20518802 17217161 11836018 21332399 18674790 18457598 16723640 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.78 | 20558911 |
OMIM:166250 |
OSTEOGLOPHONIC DYSPLASIA |
marker/mechanism |
|
| |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.38 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.69 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.37 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
12.40 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
12.40 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
12.40 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
12.40 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
12.40 | 16936753 |
MESH:D010146 |
Pain |
|
Morphine |
5.59 | 15275824 16273134 20225289 6776300 15215642 18699797 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.59 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
13.47 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
13.47 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
13.47 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
13.47 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
13.47 | 15976015 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.49 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.59 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
3.27 | 17291500 16809432 11181820 11445065 16112328 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.62 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Acrylamide |
4.52 | 11510240 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
4.87 | 11550810 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.26 | 15087411 |
MESH:D011041 |
Poisoning |
|
Diazinon |
3.79 | 17603234 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.97 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.03 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
12.74 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
12.74 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
12.74 | 11896295 11222880 11118676 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.12 | 17616702 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.16 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.13 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
9.13 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.24 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.24 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.24 | 16289102 12479363 15754350 18247401 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
2.24 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.24 | 16731767 17804756 17718901 17636462 15767336 17675339 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.24 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.24 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tocopherols |
2.24 | 12504091 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.04 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.18 | 17410198 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.17 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.17 | 10548101 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.11 | 17352296 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.95 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
9.10 | 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
9.10 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
9.10 | 15827377 16314181 16317513 17058453 17520802 |
MESH:D012135 |
Respiratory Sounds |
|
Tobacco Smoke Pollution |
4.03 | 18410779 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.25 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
3.94 | 18172121 18155124 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
4.87 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.05 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.05 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.60 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
8.64 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Dactinomycin |
8.64 | 14601052 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 16861106 |
MESH:D012640 |
Seizures |
|
Kainic Acid |
3.96 | 14637104 19414003 1641125 18657176 10686065 19186208 16336964 15686955 17827730 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.57 | 16631401 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Heparin |
5.45 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
18.19 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
18.19 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
18.19 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
18.19 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tobacco Smoke Pollution |
18.19 | 18590791 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
18.19 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Kainic Acid |
5.08 | 19414003 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.66 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
8.82 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
8.82 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.31 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
5.46 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
5.46 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
5.46 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
5.46 | 15930296 16257854 18593901 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
5.46 | 17261132 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.94 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.37 | 16684133 16045194 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.45 | 9562676 |
MESH:D013733 |
Testicular Diseases |
|
Acrylamide |
4.62 | 15864552 |
MESH:D013921 |
Thrombocytopenia |
|
Heparin |
4.91 | 16893407 16651880 |
MESH:D013927 |
Thrombosis |
|
Heparin |
4.78 | 16893407 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
4.61 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.27 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
17.41 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
17.41 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
17.41 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
17.41 | 7505956 3078959 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
17.41 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.11 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.11 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.35 | 15213294 |
OMIM:190440 |
TRIGONOCEPHALY, NONSYNDROMIC |
marker/mechanism |
|
| |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.82 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
12.77 | 20435036 11780464 12845720 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
12.77 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.77 | 17306315 16712894 16452187 11723127 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
12.77 | 8653321 16712894 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tobacco Smoke Pollution |
12.77 | 12846360 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
4.65 | 16487989 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
12.77 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
12.77 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
12.77 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.38 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.55 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
10.74 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
10.74 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.81 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.96 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Heparin |
5.45 | 20337814 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.70 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.47 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.62 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.21 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.44 | 16287080 |